APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ioversol Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ioversol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025180 pages

Choose your research edition.

Industry ResearchIoversol Injection Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Ioversol Injection Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Ioversol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ioversol Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ioversol Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ioversol Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Ioversol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ioversol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ioversol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ioversol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ioversol Injection include GUERBET, Zhejiang Starry Pharmaceutical, Hengrui Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Neptunus Bio-pharmaceutical, Liebel-Flarsheim Company LLC and Bracco Imaging S.p.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Ioversol Injection market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ioversol Injection and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ioversol Injection revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Ioversol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Ioversol Injection Segment by Company

GUERBET

Zhejiang Starry Pharmaceutical

Hengrui Pharmaceuticals

Bayer HealthCare Pharmaceuticals

Neptunus Bio-pharmaceutical

Liebel-Flarsheim Company LLC

Bracco Imaging S.p.A.

Ioversol Injection Segment by Type

50mL

75mL

100mL

125mL

Ioversol Injection Segment by Application

Hospital

Clinic

Others

Ioversol Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ioversol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ioversol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ioversol Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Ioversol Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ioversol Injection industry.

Chapter 3: Detailed analysis of Ioversol Injection companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ioversol Injectionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ioversol Injection Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 50mL Table 3. Key Players of 75mL Table 4. Key Players of 100mL Table 3. Key Players of 125mL Table 4. Global Ioversol Injection Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Others Table 8. Global Ioversol Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Ioversol Injection Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Ioversol Injection Market Share by Region (2021-2026) Table 11. Global Ioversol Injection Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Ioversol Injection Market Share by Region (2027-2032) Table 13. Ioversol Injection Industry Trends Table 14. Ioversol Injection Industry Drivers Table 15. Ioversol Injection Industry Opportunities and Challenges Table 16. Ioversol Injection Industry Restraints Table 17. Global Ioversol Injection Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Ioversol Injection Revenue Market Share by Company (2021-2026) Table 19. Global Ioversol Injection Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Ioversol Injection Key Company Head Office and Area Served Table 21. Global Ioversol Injection Company, Product Type & Application Table 22. Global Ioversol Injection Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Ioversol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Ioversol Injection Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ioversol Injection Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Ioversol Injection Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Ioversol Injection Revenue Market Share by Type (2021-2026) Table 29. Global Ioversol Injection Revenue Market Share by Type (2027-2032) Table 30. Global Ioversol Injection Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Ioversol Injection Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Ioversol Injection Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Ioversol Injection Revenue Market Share by Application (2021-2026) Table 34. Global Ioversol Injection Revenue Market Share by Application (2027-2032) Table 35. GUERBET Company Information Table 36. GUERBET Business Overview Table 37. GUERBET Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. GUERBET Ioversol Injection Product Portfolio Table 39. GUERBET Recent Development Table 40. Zhejiang Starry Pharmaceutical Company Information Table 41. Zhejiang Starry Pharmaceutical Business Overview Table 42. Zhejiang Starry Pharmaceutical Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Zhejiang Starry Pharmaceutical Ioversol Injection Product Portfolio Table 44. Zhejiang Starry Pharmaceutical Recent Development Table 45. Hengrui Pharmaceuticals Company Information Table 46. Hengrui Pharmaceuticals Business Overview Table 47. Hengrui Pharmaceuticals Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Hengrui Pharmaceuticals Ioversol Injection Product Portfolio Table 49. Hengrui Pharmaceuticals Recent Development Table 50. Bayer HealthCare Pharmaceuticals Company Information Table 51. Bayer HealthCare Pharmaceuticals Business Overview Table 52. Bayer HealthCare Pharmaceuticals Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bayer HealthCare Pharmaceuticals Ioversol Injection Product Portfolio Table 54. Bayer HealthCare Pharmaceuticals Recent Development Table 55. Neptunus Bio-pharmaceutical Company Information Table 56. Neptunus Bio-pharmaceutical Business Overview Table 57. Neptunus Bio-pharmaceutical Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Neptunus Bio-pharmaceutical Ioversol Injection Product Portfolio Table 59. Neptunus Bio-pharmaceutical Recent Development Table 60. Liebel-Flarsheim Company LLC Company Information Table 61. Liebel-Flarsheim Company LLC Business Overview Table 62. Liebel-Flarsheim Company LLC Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Liebel-Flarsheim Company LLC Ioversol Injection Product Portfolio Table 64. Liebel-Flarsheim Company LLC Recent Development Table 65. Bracco Imaging S.p.A. Company Information Table 66. Bracco Imaging S.p.A. Business Overview Table 67. Bracco Imaging S.p.A. Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Bracco Imaging S.p.A. Ioversol Injection Product Portfolio Table 69. Bracco Imaging S.p.A. Recent Development Table 70. North America Ioversol Injection Market Size by Type (2021-2026) & (US$ Million) Table 71. North America Ioversol Injection Market Size by Type (2027-2032) & (US$ Million) Table 72. North America Ioversol Injection Market Size by Application (2021-2026) & (US$ Million) Table 73. North America Ioversol Injection Market Size by Application (2027-2032) & (US$ Million) Table 74. North America Ioversol Injection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Ioversol Injection Market Size by Country (2021-2026) Table 76. North America Ioversol Injection Market Size by Country (2027-2032) Table 77. Europe Ioversol Injection Market Size by Type (2021-2026) & (US$ Million) Table 78. Europe Ioversol Injection Market Size by Type (2027-2032) & (US$ Million) Table 79. Europe Ioversol Injection Market Size by Application (2021-2026) & (US$ Million) Table 80. Europe Ioversol Injection Market Size by Application (2027-2032) & (US$ Million) Table 81. Europe Ioversol Injection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Ioversol Injection Market Size by Country (2021-2026) Table 83. Europe Ioversol Injection Market Size by Country (2027-2032) Table 84. China Ioversol Injection Market Size by Type (2021-2026) & (US$ Million) Table 85. China Ioversol Injection Market Size by Type (2027-2032) & (US$ Million) Table 86. China Ioversol Injection Market Size by Application (2021-2026) & (US$ Million) Table 87. China Ioversol Injection Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Ioversol Injection Market Size by Type (2021-2026) & (US$ Million) Table 89. Asia Ioversol Injection Market Size by Type (2027-2032) & (US$ Million) Table 90. Asia Ioversol Injection Market Size by Application (2021-2026) & (US$ Million) Table 91. Asia Ioversol Injection Market Size by Application (2027-2032) & (US$ Million) Table 92. Asia Ioversol Injection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Ioversol Injection Market Size by Country (2021-2026) Table 94. Asia Ioversol Injection Market Size by Country (2027-2032) Table 95. South America, Middle East & Africa Ioversol Injection Market Size by Type (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa Ioversol Injection Market Size by Type (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa Ioversol Injection Market Size by Application (2021-2026) & (US$ Million) Table 98. South America, Middle East & Africa Ioversol Injection Market Size by Application (2027-2032) & (US$ Million) Table 99. South America, Middle East & Africa Ioversol Injection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. South America, Middle East & Africa Ioversol Injection Market Size by Country (2021-2026) Table 101. South America, Middle East & Africa Ioversol Injection Market Size by Country (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Ioversol Injection Product Image Figure 2. Global Ioversol Injection Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Ioversol Injection Market Share by Type: 2025 VS 2032 Figure 4. 50mL Image Figure 5. 75mL Image Figure 6. 100mL Image Figure 7. 125mL Image Figure 8. Global Ioversol Injection Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Ioversol Injection Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Ioversol Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 15. Global Ioversol Injection Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Ioversol Injection Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Ioversol Injection Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Ioversol Injection Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Ioversol Injection Revenue Market Share by Type (2021-2032) Figure 22. Global Ioversol Injection Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Ioversol Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 25. North America Ioversol Injection Market Share by Type (2021-2032) Figure 26. North America Ioversol Injection Market Share by Application (2021-2032) Figure 27. North America Ioversol Injection Market Share by Country (2021-2032) Figure 28. United States Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 29. Canada Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 31. Europe Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 32. Europe Ioversol Injection Market Share by Type (2021-2032) Figure 33. Europe Ioversol Injection Market Share by Application (2021-2032) Figure 34. Europe Ioversol Injection Market Share by Country (2021-2032) Figure 35. Germany Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 36. France Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 38. Italy Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 39. Russia Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 41. China Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 42. China Ioversol Injection Market Share by Type (2021-2032) Figure 43. China Ioversol Injection Market Share by Application (2021-2032) Figure 44. Asia Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 45. Asia Ioversol Injection Market Share by Type (2021-2032) Figure 46. Asia Ioversol Injection Market Share by Application (2021-2032) Figure 47. Asia Ioversol Injection Market Share by Country (2021-2032) Figure 48. Japan Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 52. India Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 53. Australia Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Ioversol Injection Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Ioversol Injection Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Ioversol Injection Market Share by Country (2021-2032) Figure 58. Brazil Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 63. UAE Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 65. Chile Ioversol Injection Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 50mL
  • 75mL
  • 100mL
  • 125mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • GUERBET
  • Zhejiang Starry Pharmaceutical
  • Hengrui Pharmaceuticals
  • Bayer HealthCare Pharmaceuticals
  • Neptunus Bio-pharmaceutical
  • Liebel-Flarsheim Company LLC
  • Bracco Imaging S.p.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Ioversol Injection Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 50mL
  5. 1.2.3 75mL
  6. 1.2.4 100mL
  7. 1.2.5 125mL
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Ioversol Injection Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Ioversol Injection Growth Trends by Region
  15. 1.5.1 Global Ioversol Injection Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Ioversol Injection Market Size by Region (2021-2026)
  17. 1.5.3 Ioversol Injection Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Ioversol Injection Market Dynamics
  1. 2.1 Ioversol Injection Industry Trends
  2. 2.2 Ioversol Injection Industry Drivers
  3. 2.3 Ioversol Injection Industry Opportunities and Challenges
  4. 2.4 Ioversol Injection Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Ioversol Injection Revenue by Company (2021-2026)
  2. 3.2 Global Ioversol Injection Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Ioversol Injection Key Company Head office and Area Served
  4. 3.4 Global Ioversol Injection Company, Product Type & Application
  5. 3.5 Global Ioversol Injection Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Ioversol Injection Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Ioversol Injection Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Ioversol Injection Tier 1, Tier 2, and Tier 3
4 Ioversol Injection Market by Type
  1. 4.1 Global Ioversol Injection Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Ioversol Injection Market Size by Type (2021-2032)
  3. 4.3 Global Ioversol Injection Market Size Share by Type (2021-2032)
5 Ioversol Injection Market by Application
  1. 5.1 Global Ioversol Injection Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Ioversol Injection Market Size by Application (2021-2032)
  3. 5.3 Global Ioversol Injection Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GUERBET
  2. 6.1.1 GUERBET Company Information
  3. 6.1.2 GUERBET Business Overview
  4. 6.1.3 GUERBET Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GUERBET Ioversol Injection Product Portfolio
  6. 6.1.5 GUERBET Recent Developments
  7. 6.2 Zhejiang Starry Pharmaceutical
  8. 6.2.1 Zhejiang Starry Pharmaceutical Company Information
  9. 6.2.2 Zhejiang Starry Pharmaceutical Business Overview
  10. 6.2.3 Zhejiang Starry Pharmaceutical Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Zhejiang Starry Pharmaceutical Ioversol Injection Product Portfolio
  12. 6.2.5 Zhejiang Starry Pharmaceutical Recent Developments
  13. 6.3 Hengrui Pharmaceuticals
  14. 6.3.1 Hengrui Pharmaceuticals Company Information
  15. 6.3.2 Hengrui Pharmaceuticals Business Overview
  16. 6.3.3 Hengrui Pharmaceuticals Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Hengrui Pharmaceuticals Ioversol Injection Product Portfolio
  18. 6.3.5 Hengrui Pharmaceuticals Recent Developments
  19. 6.4 Bayer HealthCare Pharmaceuticals
  20. 6.4.1 Bayer HealthCare Pharmaceuticals Company Information
  21. 6.4.2 Bayer HealthCare Pharmaceuticals Business Overview
  22. 6.4.3 Bayer HealthCare Pharmaceuticals Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bayer HealthCare Pharmaceuticals Ioversol Injection Product Portfolio
  24. 6.4.5 Bayer HealthCare Pharmaceuticals Recent Developments
  25. 6.5 Neptunus Bio-pharmaceutical
  26. 6.5.1 Neptunus Bio-pharmaceutical Company Information
  27. 6.5.2 Neptunus Bio-pharmaceutical Business Overview
  28. 6.5.3 Neptunus Bio-pharmaceutical Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Neptunus Bio-pharmaceutical Ioversol Injection Product Portfolio
  30. 6.5.5 Neptunus Bio-pharmaceutical Recent Developments
  31. 6.6 Liebel-Flarsheim Company LLC
  32. 6.6.1 Liebel-Flarsheim Company LLC Company Information
  33. 6.6.2 Liebel-Flarsheim Company LLC Business Overview
  34. 6.6.3 Liebel-Flarsheim Company LLC Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Liebel-Flarsheim Company LLC Ioversol Injection Product Portfolio
  36. 6.6.5 Liebel-Flarsheim Company LLC Recent Developments
  37. 6.7 Bracco Imaging S.p.A.
  38. 6.7.1 Bracco Imaging S.p.A. Company Information
  39. 6.7.2 Bracco Imaging S.p.A. Business Overview
  40. 6.7.3 Bracco Imaging S.p.A. Ioversol Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Bracco Imaging S.p.A. Ioversol Injection Product Portfolio
  42. 6.7.5 Bracco Imaging S.p.A. Recent Developments
7 North America
  1. 7.1 North America Ioversol Injection Market Size (2021-2032)
  2. 7.2 North America Ioversol Injection Market Size by Type
  3. 7.2.1 North America Ioversol Injection Market Size by Type (2021-2026)
  4. 7.2.2 North America Ioversol Injection Market Size by Type (2027-2032)
  5. 7.2.3 North America Ioversol Injection Market Share by Type (2021-2032)
  6. 7.3 North America Ioversol Injection Market Size by Application
  7. 7.3.1 North America Ioversol Injection Market Size by Application (2021-2026)
  8. 7.3.2 North America Ioversol Injection Market Size by Application (2027-2032)
  9. 7.3.3 North America Ioversol Injection Market Share by Application (2021-2032)
  10. 7.4 North America Ioversol Injection Market Size by Country
  11. 7.4.1 North America Ioversol Injection Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Ioversol Injection Market Size by Country (2021-2026)
  13. 7.4.3 North America Ioversol Injection Market Size by Country (2027-2032)
  14. 7.4.4 North America Ioversol Injection Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Ioversol Injection Market Size (2021-2032)
  2. 8.2 Europe Ioversol Injection Market Size by Type
  3. 8.2.1 Europe Ioversol Injection Market Size by Type (2021-2026)
  4. 8.2.2 Europe Ioversol Injection Market Size by Type (2027-2032)
  5. 8.2.3 Europe Ioversol Injection Market Share by Type (2021-2032)
  6. 8.3 Europe Ioversol Injection Market Size by Application
  7. 8.3.1 Europe Ioversol Injection Market Size by Application (2021-2026)
  8. 8.3.2 Europe Ioversol Injection Market Size by Application (2027-2032)
  9. 8.3.3 Europe Ioversol Injection Market Share by Application (2021-2032)
  10. 8.4 Europe Ioversol Injection Market Size by Country
  11. 8.4.1 Europe Ioversol Injection Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Ioversol Injection Market Size by Country (2021-2026)
  13. 8.4.3 Europe Ioversol Injection Market Size by Country (2027-2032)
  14. 8.4.4 Europe Ioversol Injection Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Ioversol Injection Market Size (2021-2032)
  2. 9.2 China Ioversol Injection Market Size by Type
  3. 9.2.1 China Ioversol Injection Market Size by Type (2021-2026)
  4. 9.2.2 China Ioversol Injection Market Size by Type (2027-2032)
  5. 9.2.3 China Ioversol Injection Market Share by Type (2021-2032)
  6. 9.3 China Ioversol Injection Market Size by Application
  7. 9.3.1 China Ioversol Injection Market Size by Application (2021-2026)
  8. 9.3.2 China Ioversol Injection Market Size by Application (2027-2032)
  9. 9.3.3 China Ioversol Injection Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Ioversol Injection Market Size (2021-2032)
  2. 10.2 Asia Ioversol Injection Market Size by Type
  3. 10.2.1 Asia Ioversol Injection Market Size by Type (2021-2026)
  4. 10.2.2 Asia Ioversol Injection Market Size by Type (2027-2032)
  5. 10.2.3 Asia Ioversol Injection Market Share by Type (2021-2032)
  6. 10.3 Asia Ioversol Injection Market Size by Application
  7. 10.3.1 Asia Ioversol Injection Market Size by Application (2021-2026)
  8. 10.3.2 Asia Ioversol Injection Market Size by Application (2027-2032)
  9. 10.3.3 Asia Ioversol Injection Market Share by Application (2021-2032)
  10. 10.4 Asia Ioversol Injection Market Size by Country
  11. 10.4.1 Asia Ioversol Injection Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Ioversol Injection Market Size by Country (2021-2026)
  13. 10.4.3 Asia Ioversol Injection Market Size by Country (2027-2032)
  14. 10.4.4 Asia Ioversol Injection Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Ioversol Injection Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Ioversol Injection Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Ioversol Injection Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Ioversol Injection Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Ioversol Injection Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Ioversol Injection Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Ioversol Injection Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Ioversol Injection Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Ioversol Injection Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Ioversol Injection Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Ioversol Injection Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Ioversol Injection Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Ioversol Injection Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Ioversol Injection Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst